研究方向：抗癌化合物的设计合成

在读期间发表论文：

1. Deng JG, Yu P, Zhang ZL, Wang J, Cai JH, Wu N, Sun HB, Liang H*, Yang F*. Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands. European Journal of Medicinal Chemistry, 2018, 158: 442−452.

2. Mo QY^#, Deng JG^#, Liu YN, Huang GD, Li ZW, Yu P, Gou Y*, Yang F*. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity. European Journal of Medicinal Chemistry, 2018, 156: 368−380.

3. Yu P^#, Deng JG^#, Cai JH, Zhang ZL, Zhang JZ, Khan MH, Liang H*, Yang F*. Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex. Metallomics, 2019, 11, 1372−1386.

4. Deng JG, Yu P, Zhang ZL, Zhang JZ, Zhewen S, Cai ML, Yuan HL, Liang H*, Yang F*. Novel Pt(ii) complexes with modified aroyl-hydrazone schiff-base ligands: synthesis, cytotoxicity and action mechanism. Metallomics, 2019, 11: 1847−1863.

5. Deng JG, Wang J, Khan MH, Yu P, Yang F*, Liang H*. Structure and biological properties of five Pt(II) complexes as potential anticancer agents. Journal of Inorganic Biochemistry, 2018, 185: 10−16.

学习经历：

2014/09-2019/12，广西师范大学化学与药学学院(博士)，在职博士

毕业去向：

现就职于桂林医学院附属医院临床药学教研室，主任药师

邮箱：631104246@qq.com